Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

"Unpatients" in haemostasis and thrombosis. A yardstick of current paths in healthy carriers of a genetic susceptibility.

European journal of internal medicine - 1 Aug 2026

Di Minno G

Abstract excerpt

"Unpatients" are health-conscious individuals -carrying a genetic susceptibility whose impact is unclear with respect to the risk of a clinical event- who may shape their lives around periodic check-ups and preventive measures. Here, information from likely pathogenic single nucleotide polymorphisms (SNPs) and variants of uncertain significance in haemostasis are used to highlight current issues and directions...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Artificial Intelligence
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Risk Score

Share to Hemostasis

Share to Polymorphism, Single Nucleotide

Share to Risk Factors

Share to Thrombosis

Share to Venous Thromboembolism

Source

Identifiers

PMID: 41956942
DOI: 10.1016/j.ejim.2026.106867

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

"Unpatients" in haemostasis and thrombosis. A yardstick of current paths in healthy carriers of a genetic susceptibility.PMID 41956942Read ↗

Genomic susceptibility in practice: The regulatory trajectory of non-rare thrombophilia (NRT) genetic tests in the clinical management of venous thrombo-embolism (VTE).Semantic proximity Read ↗

Delineating the Hemostaseome as an aid to individualize the analysis of the hereditary basis of thrombotic and bleeding disorders.Semantic proximity Read ↗

High definition analyses of single cohort, whole genome sequencing data provides a direct route to defining sub-phenotypes and personalising medicineSemantic proximity Read ↗

Screening, testing, or personalized medicine: where do inherited thrombophilias fit best?Semantic proximity Read ↗

Hemostatic phenotypes and genetic disordersSemantic proximity Read ↗

DNA variant classification-reconsidering "allele rarity" and "phenotype" criteria in ACMG/AMP guidelines.Semantic proximity Read ↗

Laboratory testing for heritable thrombophilia: impact on clinical management of thrombotic disease annotation.Semantic proximity Read ↗

Genomic medicine and thrombotic risk: who, when, how and why?Semantic proximity Read ↗

The effects of pathogenic and likely pathogenic variants for inherited hemostasis disorders in 140 214 UK Biobank participantsSemantic proximity Read ↗

Testing for inherited thrombophilia and consequences for antithrombotic prophylaxis in patients with venous thromboembolism and their relativesSemantic proximity Read ↗

[Susceptibility genetics of common conditions in clinical practice].Semantic proximity Read ↗

Guidelines for investigating causality of sequence variants in human disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.